
CHF Solutions, Inc. EBITDA 2011-2025 | CHFS
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Medical devices industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
254 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
-11.5 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-815 K | - | 3.58 % | $ 2.21 M | ||
|
Boston Scientific Corporation
BSX
|
3.87 B | $ 96.13 | 0.04 % | $ 141 B | ||
|
Conformis
CFMS
|
-42.2 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-3.98 M | - | - | $ 1.77 B | ||
|
Cardiovascular Systems
CSII
|
-32.1 M | - | 0.15 % | $ 844 M | ||
|
Apyx Medical Corporation
APYX
|
-16.6 M | $ 3.6 | - | $ 125 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-9.8 M | - | -5.86 % | $ 30.6 M | ||
|
Cutera
CUTR
|
-148 M | - | -10.19 % | $ 1.99 M | ||
|
Bio-Rad Laboratories
BIO
|
421 M | $ 301.75 | 0.24 % | $ 8.51 B | ||
|
Apollo Endosurgery
APEN
|
-30.2 M | - | - | $ 475 M | ||
|
Eargo
EAR
|
-106 M | - | - | $ 10.2 M | ||
|
BioSig Technologies
BSGM
|
-12.7 M | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
437 M | $ 48.12 | 0.21 % | $ 7.17 K | ||
|
Abbott Laboratories
ABT
|
8.16 B | $ 124.81 | 0.22 % | $ 217 B | ||
|
CryoLife, Inc.
CRY
|
23.2 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
-18 M | $ 2.97 | 4.58 % | $ 111 M | ||
|
Soliton, Inc.
SOLY
|
-14.1 M | - | -1.42 % | $ 435 M | ||
|
IRIDEX Corporation
IRIX
|
-8.91 M | $ 1.14 | 3.64 % | $ 18.4 M | ||
|
IRadimed Corporation
IRMD
|
22.8 M | $ 97.06 | 0.48 % | $ 1.23 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
88.4 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-8.53 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-15.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
154 M | $ 63.08 | -0.27 % | $ 3.42 B | ||
|
Dynatronics Corporation
DYNT
|
-1.97 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
-64.8 M | - | - | $ 955 M | ||
|
Medigus Ltd.
MDGS
|
-9.9 M | - | 10.28 % | $ 55.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
8.53 M | $ 9.54 | - | $ 685 M | ||
|
InMode Ltd.
INMD
|
113 M | $ 14.47 | 0.7 % | $ 1.15 B | ||
|
Second Sight Medical Products
EYES
|
-24.3 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
753 M | $ 157.84 | 0.69 % | $ 11.8 B | ||
|
Myomo
MYO
|
-10.5 M | $ 1.02 | 12.09 % | $ 7.19 M | ||
|
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
14 M | $ 0.86 | 0.43 % | $ 88.4 M | ||
|
Avinger
AVGR
|
-16.3 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-18.8 M | $ 14.49 | 0.84 % | $ 392 M | ||
|
LENSAR
LNSR
|
-7.7 M | $ 12.01 | -0.08 % | $ 138 M | ||
|
FONAR Corporation
FONR
|
9.84 M | $ 14.53 | 0.07 % | $ 95.2 M | ||
|
AxoGen
AXGN
|
3.18 M | $ 32.64 | -0.61 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
-53.2 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
-9.67 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
217 M | $ 40.17 | 1.34 % | $ 1.24 B | ||
|
NuVasive
NUVA
|
147 M | - | - | $ 2.07 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-15.9 M | $ 17.41 | 0.75 % | $ 402 M | ||
|
Globus Medical
GMED
|
420 M | $ 88.43 | -0.38 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
70.8 M | $ 12.66 | 0.56 % | $ 975 M |